View in EDS HTML Full Text PDF Full Text

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.

Saved in:
Bibliographic Details
Title: Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Authors: Ter Brugge P; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Moser SC; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Bièche I; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Kristel P; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Ibadioune S; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Eeckhoutte A; INSERM U830, Institut Curie, PSL University, 75005, Paris, France.; Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., de Bruijn R; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., van der Burg E; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Lutz C; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Annunziato S; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., de Ruiter J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Masliah Planchon J; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Vacher S; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Courtois L; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., El-Botty R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Dahmani A; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Montaudon E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Morisset L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Sourd L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Huguet L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Derrien H; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Nemati F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Chateau-Joubert S; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704, Maisons Alfort, France., Larcher T; INRA, APEX-PAnTher, Oniris, 44300, Nantes, France., Salomon A; Department of Pathology, Institut Curie, PSL University, 75005, Paris, France., Decaudin D; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Reyal F; Department of Surgery, Institut Curie, PSL University, 75005, Paris, France., Coussy F; Department of Medical Oncology, Institut Curie, PSL University, 75005, Paris, France., Popova T; INSERM U830, Institut Curie, PSL University, 75005, Paris, France.; Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Wesseling J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands., Stern MH; Genetics Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France.; INSERM U830, Institut Curie, PSL University, 75005, Paris, France.; Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France., Jonkers J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, Netherlands. j.jonkers@nki.nl., Marangoni E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 Rue d'Ulm, 75005, Paris, France. Elisabetta.marangoni@curie.fr.
Source: Nature communications [Nat Commun] 2023 Apr 07; Vol. 14 (1), pp. 1958. Date of Electronic Publication: 2023 Apr 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-023-37537-2